Home > Back to Publisher > Report Information

Chinese Markets for Biopharmaceuticals

Asia Market Information & Development Company
February 1, 2009
200 Pages - SKU: ASM2090167

Abstract Table of Contents Search inside this report Related Reports

Countries covered: China

China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

I. INTRODUCTION: Report Scope and Methodology; Executive Summary
II. BUSINESS ENVIRONMENT: Economic Outlook; Key Economic Indicators; Industrial Output; Population and Labor; Foreign Investment; Foreign Trade; Financial and Tax Regulations; Banking System and Regulations; Foreign Exchange; Taxes, Tariff and Custom Duties
III. BIOPHARMACEUTICALS INDUSTRY ASSESSMENTS: Biopharmaceuticals Industry Structure; Market Size; Market Growth Driver; Biopharmaceuticals Sales Volume; Major Producer Facility Locations and Sales Volume; Market Share of Key Producers; Labor Cost; Potential Entrants; Major Distributors; Major Foreign Investments; Technology Development
IV. BIOPHARMACEUTICALS PRODUCTION AND DEMAND: Overview; Demand of Biopharmaceuticals by Region in 2008; Over-the-Counter (Biopharmaceuticals) Production and Demand; Biotechnology Vaccines; Major Manufacturers; Supply and Demand; CSF; Major Manufacturers; Supply and Demand; EPO; Major Manufacturers; Supply and Demand; Recombinant Human Insulin; Major Manufacturers; Supply and Demand; Recombinant Human Growth Hormones; Major Manufacturers; Supply and Demand; Recombinant Interferon; Supply and Demand; Recombinant Interleukin; Major Manufacturers; Supply and Demand; Other Biopharmaceuticals; Biopharmaceuticals Imports and Exports; Pricing Trends
V. CHINA BIOPHARMACEUTICALS MARKET OUTLOOK: Biopharmaceuticals Markets Outlook; Government Regulations; Health Care Insurance Industry Overview; Consumer Spending Trends; Demographic Trends; Health Care Industry Trends; Hospitals and Hospital Beds; Physicians and Physician Visits
VI. MARKETING STRATEGIES: China Market Entry Overview; China’s Distribution System; Biopharmaceuticals Distribution Channels; Transportation and Freight Infrastructure; Communications; China’s Market Entry; Export to China; Indirect export; Direct Export; License and Contract Manufacture; Assembling in China; Contract Manufacturing; Trade Permit; Investment; Equity Joint Venture; Contractual Joint Venture; Wholly Foreign-Owned Enterprise
VII. BIOPHARMACEUTICALS PRODUCER DIRECTORY: Biopharmaceuticals Producer Profiles and Directory; Major End-Users
LIST OF TABLES
I. INTRODUCTION: Economic Outlook Summary
II. BUSINESS ENVIRONMENT: Key Economic Indicators; Industrial Output; Population and Labor Force Trends; Foreign Investment and Loans; Foreign Trade
III. BIOPHARMACEUTICALS INDUSTRY ASSESSMENTS: Biopharmaceuticals Sales Volume; Major Producer Facility Location; Major Biopharmaceuticals Producer Sales Volume; Market Share of Key Producers; Major Foreign Investment in China
IV. BIOPHARMACEUTICALS PRODUCTION AND DEMAND: Biopharmaceuticals Sales Volume; Demand of Biopharmaceuticals by Region in 2008; Biotechnology Vaccines Sales Volume; CSF Sales Volume; EPO Sales Volume; Recombinant Human Insulin Sales Volume; Recombinant Human Growth Hormones Sales Volume; Recombinant Interferon Sales Volume; Recombinant Interleukin Sales Volume; Other Biopharmaceuticals Sales Volume; China Biopharmaceuticals Imports and Exports
V. BIOPHARMACEUTICALS MARKET OUTLOOK: Total Biopharmaceuticals Sales Volume by Market; Consumer Spending Trends; Demographic Trends; Health Care Industry Trends; Hospitals and Hospital Beds; Physicians and Physician Visits
LIST OF CHARTS
I. INTRODUCTION: China’s Biopharmaceuticals Sales Volume
II. BUSINESS ENVIRONMENT: China’s GDP and Growth Rate; Specialty Output by Ownership; China’s Imports and Exports
III. BIOPHARMACEUTICALS PRODUCTION AND DEMAND: Biopharmaceuticals Sales Volume in China
IV. BIOPHARMACEUTICALS PRODUCTION AND DEMAND: Biotechnology Vaccines Sales Volume; CSF Sales Volume; EPO Sales Volume; Recombinant Human Insulin Sales Volume; Recombinant Human Growth Hormones Sales Volume; Recombinant Interferon Sales Volume; Recombinant Interleukin Sales Volume; Other Biopharmaceuticals Sales Volume; Total biopharmaceuticals Imports and Exports
V. BIOPHARMACEUTICALS MARKET OUTLOOK
VI. MARKETING STRATEGIES: China’s Distribution Channel

More China Biopharmaceuticals Reports

Research Report on Chinese Bio-pharmaceutical Industry, 2012 by China Research and Intelligence Co., Ltd.
In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). ...

Biosimilars: China Update by Datamonitor
Biosimilars: China Update provides analysis on the Chinese biogenerics market. It includes an overview of drivers and resistors to biogeneric uptake, market access strategies, key ...

Biosimilars: China Update by Datamonitor
Currently, there is no definition, guidance or pathway for biosimilars in China, with domestically manufactured versions of biologics, known as biogenerics. Due to limited R&D ...

Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products China Pharmaceutical Guidebook Series (4) (4th edition) by Access China Management Consulting Ltd.
The biopharmaceutical industry is one of the burgeoning industries. In the field of biopharmaceuticals, vast knowledge awaits people to explore. The biopharmaceuticals are diversified and ...

Research Report on China's Biopharmaceutical Industry, 2010-2012 by China Research and Intelligence Co., Ltd.
In China, biological products for human use include bacterial vaccines (including toxoid), viral vaccines, antitoxin and immune serum, blood products, cytokines, in vivo and in ...

See all reports like this >>

More China Reports

D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

Country Report China February 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Country Report China January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

D&B Country Report: China by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Juice – China – a snapshot (2010) by Mintel - Snapshots
Juice in China by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. The report covers packaged ...

See all reports like this >>

Chinese Markets for Biopharmaceuticals

Share this report

Other tasks

Research Assistance

Related Markets

Biopharmaceuticals Reports

Free Alert Me service